{"id":"NCT03408730","sponsor":"VBI Vaccines Inc.","briefTitle":"Lot-to-lot Consistency of Sci-B-Vac™ in Adults","officialTitle":"A Double-blind Randomized Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in Adults (CONSTANT)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-12-14","primaryCompletion":"2019-10-01","completion":"2019-10-01","firstPosted":"2018-01-24","resultsPosted":"2020-10-14","lastUpdate":"2021-03-25"},"enrollment":2838,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Hepatitis B Vaccines"],"interventions":[{"type":"BIOLOGICAL","name":"Hepatitis B Vaccination","otherNames":[]}],"arms":[{"label":"Sci-B-Vac Lot A Hep B Vaccination","type":"EXPERIMENTAL"},{"label":"Sci-B-Vac Lot B Hep B Vaccination","type":"EXPERIMENTAL"},{"label":"Sci-B-Vac Lot C Hep B Vaccination","type":"EXPERIMENTAL"},{"label":"Comparator: ENGERIX-B Hep B Vaccination","type":"ACTIVE_COMPARATOR"}],"summary":"A Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in Adults","primaryOutcome":{"measure":"Geometric Mean Concentration (GMC) of Anti-HBs at Day 196 for Lot-to-Lot Consistency (Per Protocol Set 1)","timeFrame":"4 weeks after third vaccination (Study Day 196)","effectByArm":[{"arm":"Sci-B-Vac Lot A Hep B Vaccination","deltaMin":5883.93,"sd":5.423},{"arm":"Sci-B-Vac Lot B Hep B Vaccination","deltaMin":4824.06,"sd":6.293},{"arm":"Sci-B-Vac Lot C Hep B Vaccination","deltaMin":5505.98,"sd":5.975}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":22},"locations":{"siteCount":26,"countries":["United States","Belgium","Canada","Finland","Germany","United Kingdom"]},"refs":{"pmids":["34636914"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":712},"commonTop":["Headache","Upper respiratory tract infection","Nasopharyngitis","Dysmenorrhoea","Fatigue"]}}